Northwestern Mutual Wealth Management
ADCT icon

Northwestern Mutual Wealth Management’s ADC Therapeutics ADCT Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-36
Closed -$113 – 3588
2024
Q3 		$113 Buy
+36
New +$114 ﹤0.01% 3481
2024
Q1 		– Sell
-100
Closed -$166 – 3559
2023
Q4 		$166 Buy
+100
New +$92 ﹤0.01% 3359
2023
Q3 		– Sell
-100
Closed -$215 – 3269
2023
Q2 		$215 Buy
+100
New +$225 ﹤0.01% 3240

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northwestern Mutual Wealth Management's ADCT Position: Q4 2024 in Review

Northwestern Mutual Wealth Management sold out of ADC Therapeutics (ADCT) in Q4 2024, closing a stake of 36 shares — an estimated $113 sold.

Northwestern Mutual Wealth Management first reported a position in ADCT in Q2 2023 and held it in 3 quarters. The position peaked at $215 in Q2 2023. 83 funds tracked by Wall St. Rank hold ADCT as of Q4 2024.

  • Northwestern Mutual Wealth Management reported no remaining ADC Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 36 ADC Therapeutics shares in Q4 2024, an estimated $113.
  • Northwestern Mutual Wealth Management first reported a position in ADC Therapeutics in Q2 2023 and held it in 3 quarters.
  • Northwestern Mutual Wealth Management's ADC Therapeutics position peaked at $215 in Q2 2023.
  • 83 funds tracked by Wall St. Rank held ADC Therapeutics as of Q4 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2024, filed 11 Feb 2025.